Whole plant based treatment of hypercholesterolemia with Crataegus laevigata in a zebrafish model

BMC Complementary and Alternative Medicine

Volumn 12, Issue , 2012, Pages

  Littleton, Robert M ^a   Miller, Matthew ^a,b   Hove, Jay R ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CRATAEGUS; CRATAEGUS LAEVIGATA; FLOWER; HEART OUTPUT; HYPERCHOLESTEROLEMIA; LARVA; LIPID DIET; NONHUMAN; PHYTOTHERAPY; PLANT LEAF; ZEBRA FISH;

EID: 84867728195     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-12-105     Document Type: Article

References (32)

1. Nahin RL, Barnes PM, Stussman BJ, Bloom B. Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. National health statistics reports 2009, 18:1-14.
2. Rocke J, Lees J, Packham I, Chico T. The zebrafish as a novel tool for cardiovascular drug discovery. Recent Pat Cardiovasc Drug Discov 2009, 4(1):1-5.
3. Carten JD, Farber SA. A new model system swims into focus: using the zebrafish to visualize intestinal metabolism in vivo. Clin Lipidol 2009, 4(4):501-515. 10.2217/clp.09.40, 2822395, 20174460.
4. Stoletov K, Fang L, Choi SH, Hartvigsen K, Hansen LF, Hall C, Pattison J, Juliano J, Miller ER, Almazan F, et al. Vascular lipid accumulation, lipoprotein oxidation, and macrophage lipid uptake in hypercholesterolemic zebrafish. Circ Res 2009, 104(8):952-960. 10.1161/CIRCRESAHA.108.189803, 2834250, 19265037.
5. Farber SA, Pack M, Ho SY, Johnson ID, Wagner DS, Dosch R, Mullins MC, Hendrickson HS, Hendrickson EK, Halpern ME. Genetic analysis of digestive physiology using fluorescent phospholipid reporters. Science 2001, 292(5520):1385-1388. 10.1126/science.1060418, 11359013.
6. Hama K, Provost E, Baranowski TC, Rubinstein AL, Anderson JL, Leach SD, Farber SA. In vivo imaging of zebrafish digestive organ function using multiple quenched fluorescent reporters. Am J Physiol Gastrointest Liver Physiol 2009, 296(2):G445-G453. 2643917, 19056761.
7. Fang L, Harkewicz R, Hartvigsen K, Wiesner P, Choi SH, Almazan F, Pattison J, Deer E, Sayaphupha T, Dennis EA, et al. Oxidized cholesteryl esters and phospholipids in zebrafish larvae fed a high cholesterol diet: macrophage binding and activation. J Biol Chem 2010, 285(42):32343-32351. 10.1074/jbc.M110.137257, 2952235, 20710028.
8. Jin S, Cho KH. Water extracts of cinnamon and clove exhibits potent inhibition of protein glycation and anti-atherosclerotic activity in vitro and in vivo hypolipidemic activity in zebrafish. Food Chem Toxicol 2011, 49(7):1521-1529. 10.1016/j.fct.2011.03.043, 21443916.
9. Jin S, Hong JH, Jung SH, Cho KH. Turmeric and laurel aqueous extracts exhibit in vitro anti-atherosclerotic activity and in vivo hypolipidemic effects in a zebrafish model. J Med Food 2011, 14(3):247-256. 10.1089/jmf.2009.1389, 21332404.
10. Ali S, van Mil HG, Richardson MK. Large-scale assessment of the zebrafish embryo as a possible predictive model in toxicity testing. PLoS One 2011, 6(6):e21076. 10.1371/journal.pone.0021076, 3125172, 21738604.
11. Sukardi H, Chng HT, Chan EC, Gong Z, Lam SH. Zebrafish for drug toxicity screening: bridging the in vitro cell-based models and in vivo mammalian models. Expert Opin Drug Metab Toxicol 2011, 7(5):579-589. 10.1517/17425255.2011.562197, 21345150.
12. Schwerte T. Cardio-respiratory control during early development in the model animal zebrafish. Acta Histochem 2009, 111(3):230-243. 10.1016/j.acthis.2008.11.005, 19121852.
13. Chico TJ, Ingham PW, Crossman DC. Modeling cardiovascular disease in the zebrafish. Trends Cardiovasc Med 2008, 18(4):150-155. 10.1016/j.tcm.2008.04.002, 18555188.
14. McGrath P, Li CQ. Zebrafish: a predictive model for assessing drug-induced toxicity. Drug Discov Today 2008, 13(9-10):394-401.
15. Pelster B, Grillitsch S, Schwerte T. NO as a mediator during the early development of the cardiovascular system in the zebrafish. Comp Biochem Physiol A Mol Integr Physiol 2005, 142(2):215-220. 10.1016/j.cbpb.2005.05.036, 15958285.
16. Watanabe CM, Wolffram S, Ader P, Rimbach G, Packer L, Maguire JJ, Schultz PG, Gohil K. The in vivo neuromodulatory effects of the herbal medicine ginkgo biloba. Proc Natl Acad Sci U S A 2001, 98(12):6577-6580. 10.1073/pnas.111126298, 34395, 11381109.
17. Pezzuto JM, Venkatasubramanian V, Hamad M, Morris KR. Unraveling the relationship between grapes and health. J Nutr 2009, 139(9):1783S-1787S. 10.3945/jn.109.107458, 2728694, 19625701.
18. Chang WT, Dao J, Shao ZH. Hawthorn: potential roles in cardiovascular disease. Am J Chin Med 2005, 33(1):1-10. 10.1142/S0192415X05002606, 15844828.
19. Veveris M, Koch E, Chatterjee SS. Crataegus special extract WS 1442 improves cardiac function and reduces infarct size in a rat model of prolonged coronary ischemia and reperfusion. Life Sci 2004, 74(15):1945-1955. 10.1016/j.lfs.2003.09.050, 14761675.
20. Brixius K, Willms S, Napp A, Tossios P, Ladage D, Bloch W, Mehlhorn U, Schwinger RH. Crataegus special extract WS 1442 induces an endothelium-dependent, NO-mediated vasorelaxation via eNOS-phosphorylation at serine 1177. Cardiovasc Drugs Ther 2006, 20(3):177-184. 10.1007/s10557-006-8723-7, 16779533.
21. Dalli E, Colomer E, Tormos MC, Cosin-Sales J, Milara J, Esteban E, Saez G. Crataegus laevigata decreases neutrophil elastase and has hypolipidemic effect: a randomized, double-blind, placebo-controlled trial. Phytomedicine 2011, 18(8-9):769-775.
22. Rajendran S, Deepalakshmi PD, Parasakthy K, Devaraj H, Devaraj SN. Effect of tincture of Crataegus on the LDL-receptor activity of hepatic plasma membrane of rats fed an atherogenic diet. Atherosclerosis 1996, 123(1-2):235-241.
23. Zhang Z, Ho WK, Huang Y, James AE, Lam LW, Chen ZY. Hawthorn fruit is hypolipidemic in rabbits fed a high cholesterol diet. J Nutr 2002, 132(1):5-10.
24. Westerfield M. The Zebrafish Book 2000, University of Oregon Press, Eugene.
25. White RM, Sessa A, Burke C, Bowman T, LeBlanc J, Ceol C, Bourque C, Dovey M, Goessling W, Burns CE, et al. Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell 2008, 2(2):183-189. 10.1016/j.stem.2007.11.002, 2292119, 18371439.
26. Ishii H, Shimanouchi T, Umakoshi H, Walde P, Kuboi R. Analysis of the 22-NBD-cholesterol transfer between liposome membranes and its relation to the intermembrane exchange of 25-hydroxycholesterol. Colloids Surf B Biointerfaces 2010, 77(1):117-121. 10.1016/j.colsurfb.2010.01.002, 20122819.
27. Adams MR, Konaniah E, Cash JG, Hui DY. Use of NBD-cholesterol to identify a minor but NPC1L1-independent cholesterol absorption pathway in mouse intestine. Am J Physiol Gastrointest Liver Physiol 2010, 300(1):G164-G169. 3025510, 21071508.
28. Wustner D, Solanko L, Sokol E, Garvik O, Li Z, Bittman R, Korte T, Herrmann A. Quantitative assessment of sterol traffic in living cells by dual labeling with dehydroergosterol and BODIPY-cholesterol. Chem Phys Lipids 2011, 164(3):221-235. 10.1016/j.chemphyslip.2011.01.004, 21291873.
29. Holtta-Vuori M, Uronen RL, Repakova J, Salonen E, Vattulainen I, Panula P, Li Z, Bittman R, Ikonen E. BODIPY-cholesterol: a new tool to visualize sterol trafficking in living cells and organisms. Traffic 2008, 9(11):1839-1849. 10.1111/j.1600-0854.2008.00801.x, 18647169.
30. Svedstrom U, Vuorela H, Kostiainen R, Huovinen K, Laakso I, Hiltunen R. High-performance liquid chromatographic determination of oligomeric procyanidins from dimers up to the hexamer in hawthorn. J Chromatogr A 2002, 968(1-2):53-60.
31. Haghi G, Hatami A. Simultaneous Quantification of Flavonoids and Phenolic Acids in Plant Materials by a Newly Developed Isocratic High-Performance Liquid Chromatography Approach. J Agric Food Chem 2010, 58(20):10812-10816.
32. Long SR, Carey RA, Crofoot KM, Proteau PJ, Filtz TM. Effect of hawthorn (Crataegus oxycantha) crude extract and chromatographic fractions on multiple activities in a cultured cardiomyocyte assay. Phytomedicine 2006, 13(9-10):643-650.